Specialty drug management remains a top concern for health payers, including managed care organizations and employers. The 2023 State of Specialty Spend and Trend Report looks across both medical and pharmacy benefits to provide real-world data on the current state of specialty spend and trend, including management strategies.
Key Takeaways
Here’s a sneak peek into a few of the key findings
- Claim utilization continues to be the primary driver of trend (9.9%), but cost per claim played a more significant role in 2022 (3.9%)
- Specialty spend continues to shift from the medical benefit to the pharmacy benefit, the latter of which now accounts for 56.3% of spend
- The percentage of members taking at least one specialty drug continues to rise (4%), while the average number of claims per person remains steady at 5 claims per year
- Specialty trend from 2021-2022 once again reached double-digits at 14.1%
